Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

ChemoCentryx identifies new CMKLR1 receptor antagonist

April 14, 2010

RXi and TransDerm form dermatology research collaboration

April 8, 2010

Clinuvel advances afamelanotide to phase II following FDA approval of IND

March 30, 2010

Renovo's phase III Juvista trial fully recruited and on schedule

March 30, 2010

FDA approves Graceway's Zyclara NDA for actinic keratoses

March 29, 2010

Galderma discovers novel LXRbeta ligands

March 26, 2010

Garnet begins dosing in phase II trial of GBT-009 for improved scar appearance

March 24, 2010

Regenerative Medicine Assets sells ICX-TRC hair regeneration therapy to Aderans Research Institute

March 19, 2010

Studies detail PEP-005 efficacy for actinic keratoses on head and nonhead areas

March 15, 2010

Preclinical studies point to potential of NB-003 in treating acne

March 11, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...